Home › Down Syndrome › Georgia › Atlanta
Down Syndrome clinical trials in Atlanta, GA
4 studies for Down Syndrome are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
RecruitingObservational study
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
RecruitingObservational study
- Pediatrix Medical Group of Georgia, Atlanta
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
RecruitingPhase 3
- Woolfson Eye Institute, Atlanta
- Woolfson Eye Institute, Atlanta
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Houston, TX6 studies
- Phoenix, AZ6 studies
- Durham, NC6 studies
- Cincinnati, OH5 studies
- Nashville, TN5 studies
- Kansas City, KS5 studies
- Orlando, FL5 studies
- Ann Arbor, MI5 studies
- Cleveland, OH5 studies
- Philadelphia, PA5 studies
- Birmingham, AL4 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia30 studies
- Ovarian Cancer29 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Metastatic Cancer28 studies
- Heart Failure25 studies
- Major Depressive Disorder25 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.